Posting of Annual Report and Notice of AGM
Updated : 07:01
Ilika plc
("Ilika" or the "Company")
Posting of Annual Report and Notice of AGM
Notice of investor presentation
Ilika (AIM: IKA), an independent global expert in solid state battery technology, confirms that the Annual Report and Accounts for the year ended 30 April 2024 and the Notice of the 2024 Annual General Meeting ("AGM") will shortly be available to view or download by clicking the links below.
- Ilika plc Annual Report and Accounts www.ilika.com/investors/financial-reports
- Ilika plc Notice of Annual General Meeting https://www.ilika.com/investors/aim-rule-26
Notice of AGM
The AGM will be held on Tuesday 24 September 2024 at 2:00pm (BST) at the offices of Eversheds Sutherlands LLP, One Wood Street, London EC2V 7WS.
If you wish to attend the AGM in your capacity as a shareholder, please bring proof of shareholding or if shares are held through a nominee account, a letter of representation, to facilitate your entry to the meeting. If you are not planning to attend the meeting and would like someone else to vote for you at the meeting (or any adjournment of the meeting), please complete the form of proxy which can be accessed using the following link www.investorcentre.co.uk/eproxy.
Shareholders are encouraged to appoint the Chairman of the Meeting as their proxy with their voting instructions. Please vote online at www.investorcentre.co.uk/eproxy and enter the Control Number, your Shareholder Reference Number ("SRN") and PIN as shown on the Proxy Form.
To be valid, proxy appointments for the AGM must be received by the Company's Registrar, Computershare Investor Services PLC, no later than 2:00pm (BST) on Friday 20 September 2024.
Investor presentation
There will be no presentation on business operations or a Q&A session at the AGM, but the Company will host an investor presentation through the digital platform, Investor Meet Company, at 4.30pm (BST) on Tuesday 24 September 2024.
Investors can sign up to Investor Meet Company for free and add Ilika plc via the following link to join the investor presentation following the AGM: https://www.investormeetcompany.com/ilika-plc/register-investor
Investors are encouraged to pre-submit questions in advance of the presentation via the dashboard up until 9.00am (BST) on Monday 23 September 2024 or any time during the live presentation. For more information, please contact Walbrook PR at ilika@walbrookpr.com.
For more information contact: | ||
Ilika plc | ||
Graeme Purdy, Chief Executive | Via Walbrook PR | |
Jason Stewart, Chief Financial Officer | ||
Panmure Liberum Limited (Nomad and Joint Broker) | Tel: 020 3100 2000 | |
Andrew Godber, John More, | ||
Nikhil Varghese, Josh Borlant | ||
Joh. Berenberg, Gossler & Co. KG (Joint Broker) | Tel: 020 3207 8700 | |
Mark Whitmore, Detlir Elezi, | ||
Natasha Ninkov | ||
Walbrook PR Ltd | Tel: 020 7933 8780 / Ilika@walbrookpr.com | |
Nick Rome, Charlotte Edgar, Joe Walker | Mob: 07748 325 236 |
About Ilika plc - https://www.ilika.com
Ilika specialises in the developing and commercialisation of solid state batteries. The Company's mission is to rapidly develop leading-edge IP, manufacture and license solid state batteries for markets that cannot be addressed with conventional batteries due to their safety, charge rates, energy density and life limits. The Company achieves this by using ceramic-based lithium-ion technology that is inherently safe in manufacture and usage, higher thermal tolerance and easier to recycle which differentiates our products from existing batteries.
The Company has two product lines. Its Stereax batteries which are designed for powering miniature medical implants, industrial wireless sensors and specialist internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.